Homogeneous transition metal catalysis: i) asymmetric catalysis; ii) design and synthesis of supramolecular catalysts; iii) development of sustainable and efficient reduction methodologies (iron catalyzed reductions, asymmetric hydrogenation of pyridines and tandem metathesis-hydrogenation processes).
Synthesis of targeted cytotoxic agents: development of new peptide / peptidomimetic ligands of tumor-associated receptors (e.g. integrins and vascular endothelial growth factor receptors) and their conjugation to cytotoxic, pro-apoptotic or fluorescent compounds for tumor diagnosis and therapy.
"Metallaphotoredox C−O and C−N Cross-Coupling Using Donor-Acceptor Cyanoarene Photocatalysts" - T. Gandini, L. Pignataro et al. ChemCatChem 2022, DOI: 10.1002/cctc.202200990
"Advanced Pyrrolidine-Carbamate Self-Immolative Spacer with Tertiary Amine Handle Induces Superfast Cyclative Drug Release" - A. Dal Corso, C. Gennari et al. ChemMedChem 2022, DOI: 10.1002/cmdc.202200279
"Regiodivergent Reductive Opening of Epoxides by Catalytic Hydrogenation Promoted by a (Cyclopentadienone)iron Complex" - L. Pignataro, C. Gennari et al. ACS Catal. 2022, 12, 235-246, DOI: 10.1021/acscatal.1c03549